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Abstract - The objective of this study was to examine the neuroprotective effect of resveratrol on cognitive impairment 
induced by scopolamine, a muscarinic antagonist, in rats. Memory impairment was induced by administration of sco-
polamine (1 mg/kg) intraperitoneally. Cognitive functions were assessed using radial arm maze, an active avoidance 
paradigm. Oxidative stress parameters like malondialdehyde, catalase and superoxide dismutase were assessed and 
acetylcholinesterase activity was estimated. More working and reference memory errors in the radial arm maze test and 
fewer avoidances in the active avoidance test were observed with scopolamine in the 1 mg/kg i.p.-treated animals. This 
phenomenon is a clear indication of memory impairment. Oral administration of resveratrol (20 mg/kg) inhibited the 
occurrence of higher working, reference memory errors and prevented the incidence of less avoidances. Resveratrol 
appeared to have exerted memory-enhancing effects by inhibiting acetylcholinesterase activity and prevented the rise 
in malondialdehyde levels and loss of antioxidant enzymes catalase and superoxide dismutase, showing antioxidant po-
tential. Based on the above results of behavioral and biochemical studies, it can be concluded that resveratrol protected 
against scopolamine-induced loss of cognition. The results also indicate that resveratrol is an antioxidant and an acetyl-
cholinesterase inhibitor, and it is likely that resveratrol’s protective effect is related to its antioxidant and cholinesterase 
inhibitory effects.
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INTRODUCTION
The brain is the central part of our body that con-
trols physiological and cognitive functions. Billions 
of neurons in the brain connect each other to form 
communication networks. Normal brain functioning, 
including memory, is impaired when connections in 
the neurons are lost. Oxidative stress is one of the 
factors causing the death of neurons. Acetylcholine 
is the neurotransmitter present in cholinergic neu-
rons responsible for memory. A decreased level of 
acetylcholine due to the death of central cholinergic 
neurons is thought to be one of the factors for loss of 
memory (Ramakrishna et al., 2010). Loss of memory 
is the main symptom of brain damage and for a vari-
ety of disorders including Alzheimer’s disease.
Scopolamine is a muscarinic receptor antagonist 
that blocks cholinergic neurotransmission, leading 
to memory impairment in rats. Recent studies have 
reported that scopolamine induces oxidative stress 
leading to memory impairment (Fan Y et al., 2005)1382 BUNADRI PUSHPALATHA ET AL.
Many studies report that polyphenols have anti-
oxidant capacity neutralizing free radicals by cross-
ing the blood-brain barrier to protect the brain and 
nervous system. The main functions of polyphenols 
include improvements in memory, the immune sys-
tem and heart. Resveratrol is one of the naturally 
occurring  polyphenolic  antioxidant  found  in  red 
wine, grape skins, blueberries, cranberries and pea-
nuts.
The present study was undertaken to evaluate the 
neuroprotective effect of resveratrol against scopo-
lamine-induced cognitive impairment and oxidative 
stress. The objectives include evaluation of the effect 
of resveratrol on a scopolamine-induced cognitive 
impairment  model,  evaluation  of  the  antioxidant 
property of resveratrol and an estimation of the ace-
tylcholine esterase activity of resveratrol.
MATERIALS AND METHODS
Animals
All experiments were conducted using male albino 
Wistar rats (150-200 g), 6-8 weeks of age. All animals 
were obtained from Sanzyme Limited, Hyderabad. 
The animals were maintained with free access to food 
and water and kept at 25 ± 2◦C under a controlled 12 
h light/dark cycle.
Treatment schedule
Animals were weighed and divided into five groups, 
each group containing 6 animals. The animal groups 
and their treatment are given in Table 1.
The  animals  were  trained  by  conducting  one 
daily training trial during which they did not receive 
any drug. Completely trained animals were chosen 
for the study. These animals were dosed once a day 
with the respective drugs for 8 days, along with the 
daily training trial. Scopolamine was given on the 
eighth day 45 min after treatment. After one hour, all 
animals were tested on radial arm maze performance 
and the active avoidance test.
Behavioral models 
Radial arm maze
Behavioral training began after the rats were food-
deprived to 85% of their original body weight. Each 
animal was weighed daily and manually fed with 2-3 
food pellets. The food-deprived weight of the animals 
was attained within 6 days (Russell et al., 2005)
For the first phase of behavioral training, rats 
were  habituated  to  the  maze  for  four  consecutive 
days. During habituation, food pellets dipped in su-
crose solution were placed in food cups of all eight 
arms. Rats were released on the center platform and 
given  10  min  (or  until  all  food  pellets  were  con-
sumed) to explore all eight arms.
Finally, on the third and fourth days of habitua-
tion, the rats were placed in the maze for 5 min with 
one drop of sucrose solution in the food well at the 
end of each arm. On all days, the arms the rats visited 
were recorded to ensure that the rats were visiting all 
arms of the maze.
After  habituation  was  completed,  the  second 
phase of behavioral training began. Four arms were 
randomly  selected  and  baited.  Rats  were  released 
from the center platform and arm visits were record-
ed. The training trial was considered complete when 
all four pellets were consumed or 5 min had passed. 
Once all the rats had reached a set criterion of a min-
imal (average) 75% correct attempts, training with 
drugs began. These animals were dosed once a day 
with the respective drugs for 8 days, along with daily 
training trial. Scopolamine was given on eighth day 
45 min after treatment. After one hour, all animals 
were tested on the radial arm maze.
Active avoidance
Prior to avoidance training, each rat was habituated 
to the apparatus for 2 min. At the beginning of each 
session a rat was placed in the left compartment close 
to and facing the end wall. In each trial the animal 
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stimulus for 10 s. Immediately after the sound stimu-
lus, the rat received a single low intensity foot shock 
(0.5 mA; 3 s) through the grid floor. Each animal re-
ceived a daily session of 15 trials with an inter-trial 
duration of 15 s for 5 days, i.e. a maximum of 75 tri-
als. Transfer time from one compartment to another, 
number of avoidances (after the stimulus of either 
light alone or both light and sound) and escape (after 
the foot shock) response were recorded. The crite-
rion for improved cognitive activity was taken as a 
significant increase in the avoidance response on 5th 
session (retention) as compared to 1st session (train-
ing). All the behavioral models were carried out in 
a semi-dark soundproof room in order to overcome 
external interferences in the experiment (Alikatte et 
al., 2012).
Biochemical estimation of markers of oxidative stress
Biochemical tests were conducted 24 h after the last 
behavioral test. The animals were sacrificed by de-
capitation. Brains were removed and rinsed with ice-
cold isotonic saline. Brains were then homogenized 
with ice-cold phosphate buffer (pH 8). The homoge-
nates (10% w/v) were then centrifuged at 10,000rpm 
for 15 min and the supernatant formed was used for 
the biochemical estimations. 
Estimation of acetylcholinesterase activity
The acetylcholinesterase activity was estimated using 
Ellman’s method (Ellman et al., 1959). 
Estimation of superoxide dismutase
The enzyme superoxide dismutase (SOD) was deter-
mined in brain homogenate using a photo-oxidation 
method, which is briefly described (Arutla et al., 1998): 
0.88ml of riboflavin solution (1.3 × 10–5 M in 0.01M 
potassium phosphate buffer, pH 7.5) was added to 60 
ml of o-dianisidine solution (10-2 M in ethanol), and 
to this 100 ml of clear separated SOD (brain homoge-
nate) was added; optical density was measured at 460 
nm.  The  cuvette  containing  reaction  mixture  was 
transferred to the illuminating box, illuminated for 4 
min, and the optical density was remeasured against 
a blank containing ethanol in place of enzyme. The 
change in optical density was determined. 
Estimation of lipid peroxidation (LPO)
The amount of lipid peroxidation products present 
in the homogenate samples of brain was estimated by 
the thiobarbituric acid reactive substances (TBARS) 
assay  (Okhawa  et  al.,  1979)  which  measures  the 
malondialdehyde (MDA) reactive products by using 
UV-visible spectroscopy.
Estimation of catalase activity
Catalase activity was assessed by the method of Luck 
(Luck et al.,1971) wherein the breakdown of hydro-
gen peroxide is measured. 
Statistical analysis
The results were presented as the mean ± SEM. Sta-
tistical analysis was done by ANOVA followed by 
Bonferroni’s test. P< 0.05 was considered as statisti-
cally significant.
RESULTS
Effect of resveratrol on reference memory
The  occurrence  of  reference  memory  errors  was 
more in the scopolamine (1 mg/kg) treated group 
compared to the control group, indicating an induc-
tion  of  memory  impairment.  Oral  administration 
of resveratrol (20 mg/kg) showed a protective effect 
against scopolamine-induced memory impairment 
by preventing more reference memory errors (Table 
2).
Effect of resveratrol on working memory
More working memory errors were observed in the 
scopolamine-treated group when compared to the 
control group, indicating memory impairment. Oral 
administration of resveratrol (20 mg/kg) exhibited a 
protective effect against scopolamine-induced mem-
ory impairment (Table 2).1384 BUNADRI PUSHPALATHA ET AL.
Effect of resveratrol on the avoidance paradigm 
against scopolamine-induced cognitive impairment.
In active avoidance test, the number of avoidanc-
es was less in the scopolamine-treated group when 
compared with the control group, indicating mem-
ory impairment. Resveratrol (20 mg/kg) apparently 
possessed  a  protective  effect  against  scopolamine-
induced memory impairment by inhibiting the inci-
dence of a lower number of avoidances (Table 2).
Effect of resveratrol on acetylcholinesterase activity 
 in scopolamine-treated rats
In the present study, the results show that scopo-
lamine significantly elevated brain acetylcholineste-
rase activity. However, resveratrol at a dose of 20mg/
kg seemed to have memory-enhancing effects by in-
hibiting the elevation of acetylcholinesterase activity 
when compared with the scopolamine-treated group 
(Table 2).
Table 1. Animal groups and treatments.
              Groups  Treatment 
Group-I Normal control Vehicle 
Group-II Disease control Scopolamine 1 mg/kg i.p.
Group-III Standard  Piracetam ( 200mg/kg) i.p. + Scopolamine ( 1mg/kg) i.p.
Group-IV Test 1 Resveratrol ( 10 mg/kg) oral + Scopolamine ( 1mg/kg) i.p.
Group-V Test 2 Resveratrol ( 20 mg/kg) oral + Scopolamine ( 1mg/kg) i.p.
Table 2. The effect of resveratrol on various behavioral parameters and AchE levels.
Groups
No. of reference
memory errors
No. of  working  
memory errors
No. of avoidances AchE(μ moles/min/mg protein )
Normal control 0.8 ± 0.16 0.50 ± 0.22 10.83±0.30 118±1.76 
Scopolamine  2.5 ± 0.22 * 2.00 ± 0.26 * 6.167±0.30 * 206±3.11*
Piracetam 1.0 ± 0.25 # 0.83 ± 0.16 # 9.500±0.22 # 128±1.20 #
Test drug (lower dose) 1.5 ± 0.22 # 0.33 ± 0.22 # 8.167±0.16 # 165±2.17 #
Test drug (higher dose) 1.2 ± 0.16 # 1.00 ± 0.00 # 9.000±0.25 # 138±1.66 #
*P< 0.05 compared with normal control group; #p<0.05 compared with scopolamine-treated group.
Table 3. The effect of resveratrol on oxidative stress and antioxidant enzymes.
 Groups
SOD( % superoxide ion 
scavenging activity)
Catalase (% H2O2  
scavenging activity)
Lipid Peroxidation (nmoles/g 
brain tissue)
Normal control 60.99 ± 0.49 71.92 ± 0.42 26.25 ± 0.51
Scopolamine 43.78 ± 0.84 * 54.26 ± 0.76 * 46.32 ± 0.81 *
Piracetam  57.85 ± 0.65 # 68.62 ± 0.67 # 30.29 ± 0.66 #
Test (lower dose) 50.77 ± 0.33 # 60.60 ± 0.62 # 38.99 ± 0.60 #
Test (higher dose) 54.58 ± 0.55 # 64.28 ± 0.83 # 33.62 ± 0.79 #
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Effect of resveratrol on oxidative parameters in  
scopolamine-treated rat brain
The antioxidant activity of enzymes such as superox-
ide dismutase (SOD) and catalase were significantly 
inhibited  in  the  scopolamine-treated  group  when 
compared with the control group. Resveratrol signif-
icantly prevented loss of activity of these antioxidant 
enzymes  when  compared  to  scopolamine-treated 
group. 
Scopolamine  treatment  significantly  increased 
the brain malondialdehyde (MDA) levels compared 
to control group. Resveratrol significantly prevented 
the rise in brain MDA levels compared to scopo-
lamine-treated group (Table 3).
DISCUSSION
Formation of memory is a very complex process in-
volving multiple neuronal pathways and neurotrans-
mitters. The cholinergic neuronal system is known 
to play an important role in memory in humans and 
animals (Blokland et al., 1996). Based on the cholin-
ergic hypothesis, many attempts have been made to 
reverse cognitive deficits by increasing brain cholin-
ergic activity via acetylcholinesterase (AChE) inhibi-
tors.
In this neurobehavioral study, the effects of res-
veratrol  on  cognitive  parameters,  the  radial  arm 
maze and active avoidance task, after scopolamine-
induced  memory  loss  in  rats.  Radial  arm  maze 
performance is an appetitive motivation task that 
is useful to assess the spatial reference as well as 
spatial working memory performance (Kulkarni et 
al., 2005). Results of this study showed that oral ad-
ministration of resveratrol significantly prevented 
the higher reference memory and working memory 
errors, suggesting that resveratrol ameliorated the 
memory impairment.
From the active avoidance test, it was clearly seen 
that resveratrol had a protective effect, indicating a 
therapeutic efficacy of resveratrol against memory 
loss. Oxidative stress is a critical detriment factor 
stimulating neuronal cell death. Through generation 
of reactive oxygen species (ROS) resulting in oxida-
tive damage within the cell, it leads to memory defi-
cits. In the present study, resveratrol was found to 
prevent the rise in malondialdehyde levels and loss 
of antioxidant enzymes catalase and superoxide dis-
mutase, showing an antioxidant potential.
In the present study, resveratrol seemed to pre-
vent the memory-disturbing effect of scopolamine, 
probably by acting on acetylcholinesterase (AchE). 
The results of this study suggest that a decrease of 
acetylcholinesterase activity by resveratrol can con-
tribute to increased levels of acetylcholine and con-
sequently improve cognitive functions.
CONCLUSION
The present study demonstrates the beneficial effect 
of resveratrol on scopolamine-induced cognitive im-
pairment. Resveratrol significantly ameliorated the 
cognitive deficit. Resveratrol protected memory as 
shown by behavioral tests using the radial arm maze 
and active avoidance test. Based on the results of be-
havioral and biochemical studies, it can be conclud-
ed that resveratrol protected against scopolamine-
induced loss of cognition. The results also indicated 
that resveratrol is an antioxidant and an acetylcho-
linesterase  inhibitor;  suggesting  that  resveratrol’s 
protective effect were related to its antioxidant and 
cholinesterase inhibitory effects. 
REFERENCES
Alikatte, K.L., Akondi, B.R., Yerragunta, V.G., Veerareddy, P.R., 
and S. Palle (2012). Antiamnesic activity of Syzygium cum-
ini against scopolamine induced spatial memory impair-
ments in rats. Brain Dev. 34(10), 844-51. 
Arutla, S., Arra, G.S., Prabhakar, C.M. and D.R. Krishna (1998) 
Pro- and anti-oxidant effects of some antileprotic drugs in 
vitro and their influence on superoxide dismutase activity. 
Arzneim.-Forsch J Drug Res. 48, 1024.
Blokland, A. (1996) Acetylcholine: A neurotransmitter for learn-
ing and memory? Brain Res Rev. 21, 285-300.
Brown, R.W., Beale, K.S. and G.D. Jay Frye (2002). Mecamylam-
ine  blocks  enhancement  of  reference  memory  but  not 
working memory produced by post-training injection of 1386 BUNADRI PUSHPALATHA ET AL.
nicotine in rats tested on the radial arm maze. Behav Brain 
Res. 134, 259-265.
Ellman, G.L. (1959) Tissue sulfhydryl groups. Arch Biochem Bio-
phys. 82, 70-77.
Fan, Y., Hu, J. and J. Li. (2005). Effect of acidic oligosaccharide 
sugar  chain  on  scopolamine-induced  memory  impair-
ment in rats and its related mechanisms. Neurosci Lett. 
374(3), 222-6.
Kulkarni, S.K (2005) Hand book of Experimental Pharmacology. 
3rd ed. Vallabh Prakashan. P. 168-169.
Luck, H. and H.U. Bergmeyer (1971) Catalase in methods of enzy-
matic analysis. Ed., Academic Press, Newyork, NY, USA. 
P. 885-93.
Okhawa, H., Ohishi, N. and K. Yagi (1979) Assay for lipid perox-
ides in animal tissues by thiobarbituric acid reaction. Ann 
Biochem. 95, 351-58.
Ramakrishna, S., Abhinav, K., Jogender, M., Madhusudana, K., 
Vegi, G.M. and K.G. Yogendra (2010). Anti-amnesic activ-
ity of Vitex negundo in scopolamine induced amnesia in 
rats. Pharmacology and Pharmacy. 1(1), 1-8. 